Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-H

Invasion and metastasis of hepatocellular carcinoma (HCC) is a major cause for lethal liver cancer. Signaling pathways associated with cancer progression are frequently reconfigured by aberrant phosphorylation of key proteins. To capture the key phosphorylation events in HCC metastasis, we establish...

Full description

Bibliographic Details
Main Authors: Miaomiao Tian, Han Cheng, Zhiqiang Wang, Na Su, Zexian Liu, Changqing Sun, Bei Zhen, Xuechuan Hong, Yu Xue, Ping Xu
Format: Article
Language:English
Published: MDPI AG 2015-02-01
Series:International Journal of Molecular Sciences
Subjects:
HCC
Online Access:http://www.mdpi.com/1422-0067/16/2/4209
id doaj-d79a87d772154fb0b14562fb401411d8
record_format Article
spelling doaj-d79a87d772154fb0b14562fb401411d82020-11-25T00:46:41ZengMDPI AGInternational Journal of Molecular Sciences1422-00672015-02-011624209422510.3390/ijms16024209ijms16024209Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-HMiaomiao Tian0Han Cheng1Zhiqiang Wang2Na Su3Zexian Liu4Changqing Sun5Bei Zhen6Xuechuan Hong7Yu Xue8Ping Xu9State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Engineering Research Center for Protein Drugs, National Center for Protein Sciences, Beijing Institute of Radiation Medicine, Beijing 102206, ChinaDepartment of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, ChinaState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Engineering Research Center for Protein Drugs, National Center for Protein Sciences, Beijing Institute of Radiation Medicine, Beijing 102206, ChinaState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Engineering Research Center for Protein Drugs, National Center for Protein Sciences, Beijing Institute of Radiation Medicine, Beijing 102206, ChinaDepartment of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, ChinaTianjin Baodi Hospital, Tianjin 301800, ChinaState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Engineering Research Center for Protein Drugs, National Center for Protein Sciences, Beijing Institute of Radiation Medicine, Beijing 102206, ChinaKey Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan 430072, ChinaDepartment of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, ChinaState Key Laboratory of Proteomics, Beijing Proteome Research Center, National Engineering Research Center for Protein Drugs, National Center for Protein Sciences, Beijing Institute of Radiation Medicine, Beijing 102206, ChinaInvasion and metastasis of hepatocellular carcinoma (HCC) is a major cause for lethal liver cancer. Signaling pathways associated with cancer progression are frequently reconfigured by aberrant phosphorylation of key proteins. To capture the key phosphorylation events in HCC metastasis, we established a methodology by an off-line high-pH HPLC separation strategy combined with multi-step IMAC and LC–MS/MS to study the phosphoproteome of a metastatic HCC cell line, MHCC97-H (high metastasis). In total, 6593 phosphopeptides with 6420 phosphorylation sites (p-sites) of 2930 phosphoproteins were identified. Statistical analysis of gene ontology (GO) categories for the identified phosphoproteins showed that several of the biological processes, such as transcriptional regulation, mRNA processing and RNA splicing, were over-represented. Further analysis of Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations demonstrated that phosphoproteins in multiple pathways, such as spliceosome, the insulin signaling pathway and the cell cycle, were significantly enriched. In particular, we compared our dataset with a previously published phosphoproteome in a normal liver sample, and the results revealed that a number of proteins in the spliceosome pathway, such as U2 small nuclear RNA Auxiliary Factor 2 (U2AF2), Eukaryotic Initiation Factor 4A-III (EIF4A3), Cell Division Cycle 5-Like (CDC5L) and Survival Motor Neuron Domain Containing 1 (SMNDC1), were exclusively identified as phosphoproteins only in the MHCC97-H cell line. These results indicated that the phosphorylation of spliceosome proteins may participate in the metastasis of HCC by regulating mRNA processing and RNA splicing.http://www.mdpi.com/1422-0067/16/2/4209phosphorylationphosphoproteomicsmetastasisHCCspliceosome
collection DOAJ
language English
format Article
sources DOAJ
author Miaomiao Tian
Han Cheng
Zhiqiang Wang
Na Su
Zexian Liu
Changqing Sun
Bei Zhen
Xuechuan Hong
Yu Xue
Ping Xu
spellingShingle Miaomiao Tian
Han Cheng
Zhiqiang Wang
Na Su
Zexian Liu
Changqing Sun
Bei Zhen
Xuechuan Hong
Yu Xue
Ping Xu
Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-H
International Journal of Molecular Sciences
phosphorylation
phosphoproteomics
metastasis
HCC
spliceosome
author_facet Miaomiao Tian
Han Cheng
Zhiqiang Wang
Na Su
Zexian Liu
Changqing Sun
Bei Zhen
Xuechuan Hong
Yu Xue
Ping Xu
author_sort Miaomiao Tian
title Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-H
title_short Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-H
title_full Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-H
title_fullStr Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-H
title_full_unstemmed Phosphoproteomic Analysis of the Highly-Metastatic Hepatocellular Carcinoma Cell Line, MHCC97-H
title_sort phosphoproteomic analysis of the highly-metastatic hepatocellular carcinoma cell line, mhcc97-h
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2015-02-01
description Invasion and metastasis of hepatocellular carcinoma (HCC) is a major cause for lethal liver cancer. Signaling pathways associated with cancer progression are frequently reconfigured by aberrant phosphorylation of key proteins. To capture the key phosphorylation events in HCC metastasis, we established a methodology by an off-line high-pH HPLC separation strategy combined with multi-step IMAC and LC–MS/MS to study the phosphoproteome of a metastatic HCC cell line, MHCC97-H (high metastasis). In total, 6593 phosphopeptides with 6420 phosphorylation sites (p-sites) of 2930 phosphoproteins were identified. Statistical analysis of gene ontology (GO) categories for the identified phosphoproteins showed that several of the biological processes, such as transcriptional regulation, mRNA processing and RNA splicing, were over-represented. Further analysis of Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations demonstrated that phosphoproteins in multiple pathways, such as spliceosome, the insulin signaling pathway and the cell cycle, were significantly enriched. In particular, we compared our dataset with a previously published phosphoproteome in a normal liver sample, and the results revealed that a number of proteins in the spliceosome pathway, such as U2 small nuclear RNA Auxiliary Factor 2 (U2AF2), Eukaryotic Initiation Factor 4A-III (EIF4A3), Cell Division Cycle 5-Like (CDC5L) and Survival Motor Neuron Domain Containing 1 (SMNDC1), were exclusively identified as phosphoproteins only in the MHCC97-H cell line. These results indicated that the phosphorylation of spliceosome proteins may participate in the metastasis of HCC by regulating mRNA processing and RNA splicing.
topic phosphorylation
phosphoproteomics
metastasis
HCC
spliceosome
url http://www.mdpi.com/1422-0067/16/2/4209
work_keys_str_mv AT miaomiaotian phosphoproteomicanalysisofthehighlymetastatichepatocellularcarcinomacelllinemhcc97h
AT hancheng phosphoproteomicanalysisofthehighlymetastatichepatocellularcarcinomacelllinemhcc97h
AT zhiqiangwang phosphoproteomicanalysisofthehighlymetastatichepatocellularcarcinomacelllinemhcc97h
AT nasu phosphoproteomicanalysisofthehighlymetastatichepatocellularcarcinomacelllinemhcc97h
AT zexianliu phosphoproteomicanalysisofthehighlymetastatichepatocellularcarcinomacelllinemhcc97h
AT changqingsun phosphoproteomicanalysisofthehighlymetastatichepatocellularcarcinomacelllinemhcc97h
AT beizhen phosphoproteomicanalysisofthehighlymetastatichepatocellularcarcinomacelllinemhcc97h
AT xuechuanhong phosphoproteomicanalysisofthehighlymetastatichepatocellularcarcinomacelllinemhcc97h
AT yuxue phosphoproteomicanalysisofthehighlymetastatichepatocellularcarcinomacelllinemhcc97h
AT pingxu phosphoproteomicanalysisofthehighlymetastatichepatocellularcarcinomacelllinemhcc97h
_version_ 1725263734126936064